MindfulGarden Digital Health

Name

MindfulGarden Digital Health

Legal name

MindfulGarden Digital Health, Inc.

Website

https://mindfulgarden.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Digital Therapeutics - Delirium Management

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Services for the Elderly and Persons with Disabilities (624120)

SIC

Surgical & Medical Instruments & Apparatus (3841), Services-Health Services (8000)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

akta.pro secondary industry

Therapeutic Companion Apps (Drug-Device-Digital Combination) (HLACANAH)

Keywords

• Digital therapeutics platform
• Biofeedback medical device
• Delirium management system
• Non-pharmacological intervention
• Clinical biofeedback software

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Hospital Evaluation Programs: Contracts with Canadian hospital authorities for evaluation programs through 2025, with expansion to Hong Kong. Revenue derived from hospital system evaluations and pilot programs as MindfulGarden seeks clinical adoption.
2. Medical Device Sales: Class I medical device commercially available in Canada and Hong Kong. Health Canada approved (MDEL Lic.26563) in April 2024. FDA pre-submission completed targeting 2026/27 clearance.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

MindfulGarden Digital Health develops and sells a clinically validated affective biofeedback platform (MindfulGarden V.1) for managing agitated behaviors associated with in-hospital delirium. The Class I medical device combines interactive sensor technologies with nature-based visualizations, soundscapes, breathwork, and brain games to autonomously distract, engage, and de-escalate patients without pharmacological intervention, reducing reliance on antipsychotics and restraints. The platform is approved by Health Canada (MDEL Lic.26563), commercially available in Canada and Hong Kong, and pursuing US FDA clearance.

Product overview

MindfulGarden Digital Health offers a single unified product platform (MindfulGarden V.1) — a clinically validated affective biofeedback platform for managing agitated behaviors associated with in-hospital delirium. The core V.1 product combines interactive sensor technologies with nature-based visualizations, soundscapes, breathwork, and brain games to create a 'digital crashcart' for delirium management. The platform operates autonomously based on patient-generated distress signals, automatically adjusting visualizations and audio to level up or down as the patient calms. V.2 (currently in R&D) will expand the platform's capabilities by incorporating vital signs monitoring. The platform is marketed as a non-pharmacological alternative to antipsychotics and restraints, with clinical validation published in Nature npj/Digital Medicine.

Differentiator

Problem solved

Functional benefit

Products and services

• MindfulGarden V.1 A clinically validated affective biofeedback platform that combines interactive sensor technologies, nature-based visualizations, soundscapes, breathwork, and brain games to autonomously distract, engage, and de-escalate patients experiencing agitated behaviors associated with in-hospital delirium. Designed for acute care hospitals and long-term care facilities seeking a non-pharmacological alternative to antipsychotics and restraints.

Quantifiable outcome

• 25.7% reduction in PRN (as needed) antipsychotic drug use
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Partnerships

Four partnerships are on record, tiered minor.

• MatterminorOthersHealthcare technology accelerator and growth program participant.
• Creative BCminorOthersBC creative industries growth program supporting digital innovation.
• Berkeley SkyDeck (GIP Program)minorOthersUniversity accelerator program; Dr. Jeffery Wajda is a past mentor at Berkeley SkyDeck GIP Program.
• Asia Pacific AcceleratorminorOthersGrowth program supporting Asia Pacific market expansion, relevant to Hong Kong expansion plans.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Rendever: Rendever provides immersive VR experiences for seniors in hospitals, long-term care and rehabilitation settings — directly comparable to MindfulGarden's immersive biofeedback approach to calming agitated elderly and dementia patients in care environments.
• Neuroglee: Neuroglee develops digital therapeutics for individuals with cognitive decline and dementia. Both companies target the same patient population with software-based cognitive/behavioral interventions.

Emerging players

• MyndYou: MyndYou offers AI-driven cognitive assessment and personalized interventions for older adults, with relevance to MindfulGarden's elderly delirium and agitation focus.
• Altoida: Altoida develops digital biomarkers and cognitive assessments for brain health, addressing similar neurodegenerative and cognitive decline populations served by MindfulGarden's delirium platform.
• Limbic: Limbic offers AI-driven digital therapeutics and patient engagement for mental health, with overlapping interest in non-pharmacological behavioral interventions in healthcare settings.

Broad incumbents

• Akili Interactive: Akili is a publicly-traded pioneer in prescription digital therapeutics for cognitive and behavioral conditions, sharing the same regulatory-cleared SaMD business model as MindfulGarden.
• Pear Therapeutics: Pear Therapeutics was a founding DTx company developing prescription digital therapeutics across multiple indications, establishing the regulatory and reimbursement playbook MindfulGarden is pursuing.
• Click Therapeutics: Click Therapeutics develops prescription digital therapeutics across multiple indications using mobile software, operating the same SaMD business model as MindfulGarden.
• Omada Health: Omada Health is a digital therapeutics company operating in chronic disease prevention using behavioral science — sharing the digital therapeutic reimbursement and payer channel dynamics relevant to MindfulGarden's enterprise model.
• Big Health: Big Health (Sleepio, Daylight) sells digital therapeutics for insomnia and anxiety — non-pharmacological behavioral health interventions with a similar clinical evidence-driven commercialization model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/mindfulgarden
• Facebookfacebook.com/themindfulgarden
• LinkedInlinkedin.com/company/mindfulgarden

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds5 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MindfulGarden Digital Health